COVID-19 vaccines offer safe and effective protection against severe disease and are strongly recommended for everyone over the age of 5 years. While children often experience milder symptoms of disease than adults, US data obtained during the Omicron surge in cases shows a significant spike in the rates of hospitalisation in children under 5.

This article explores the immune response to COVID-19 vaccines in children of different age groups, the safety and efficacy considerations for vaccinating children under 5, and an approximate timeline for next steps regarding this cohort.

To read the article in full, please click on the link below.

The Conversation: COVID-19 vaccines for the youngest children may be inching closer to authorization – a pediatrician explains how they’re being tested